{
    "clinical_study": {
        "@rank": "58915", 
        "brief_summary": {
            "textblock": "To investigate the safety of thymic humoral factor (THF gamma 2), its effect on HIV load\n      based on at least a 75 percent decrease in HIV quantitative PCR RNA copies/ml, and its\n      persistence when administered in combination with an antiretroviral nucleoside derivative\n      (zidovudine; AZT). To assess the effects of THF gamma 2 on T-cells, quality of life, and\n      progression of disease."
        }, 
        "brief_title": "A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "All patients receive 12 weeks of AZT before being randomized to self-administer one of two\n      doses of THF gamma 2 or placebo for 15 consecutive days and then twice weekly for an\n      additional 50 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  AZT or another antiretroviral agent (marketed or investigational under a Treatment\n             IND).\n\n          -  Primary prophylaxis for Pneumocystis carinii pneumonia (PCP), toxoplasmosis, and\n             Mycobacterium avium-intracellulare (MAI) if patient's CD4 count decreases to < 200\n             cells/mm3.\n\n          -  Other marketed drugs as required.\n\n        Patients must have:\n\n          -  HIV seropositivity and be either asymptomatic or have persistent generalized\n             lymphadenopathy (PGL).\n\n          -  No history of symptoms in Category B or C of 1993 Case Definition, other than oral\n             candidiasis following previous broad-spectrum antibiotic therapy.\n\n          -  Mean CD4 of 200-500 cells/mm3.\n\n          -  HIV-1 positive PCR RNA.\n\n          -  Ability to self-administer study drug by IM injection.\n\n          -  Ability to tolerate AZT at 600 mg daily during first 8 weeks of run-in period (if AZT\n             naive) OR tolerated AZT at >= 500 mg daily for at least 3 months but no more than 12\n             months prior to randomization.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Malignancy.\n\n          -  Hematuria.\n\n          -  Proteinuria > 1+.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Non-antiretroviral agents with known or suspected activity against HIV.\n\n          -  Investigational new drugs that are not antiretroviral agents distributed under a\n             Treatment IND.\n\n        Patients with the following prior conditions are excluded:\n\n        Myositis within the past 6 months.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Experimental therapy, including interleukin-2, interferon, erythropoietin, or\n             filgrastim nucleoside within 6 weeks prior to study entry.\n\n          -  Prior antiretroviral therapy (AZT-naive patients only).\n\n        Prior Treatment:\n\n        Excluded within 6 weeks prior to study entry:\n\n          -  Blood transfusion or blood products. Active alcoholism, drug abuse, or a mental or\n             psychiatric problem sufficient to prevent adequate compliance with study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002435", 
            "org_study_id": "136A", 
            "secondary_id": "CS 112010-999"
        }, 
        "intervention": [
            {
                "intervention_name": "Thymic Humoral Factor", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Zidovudine", 
                "Thymic humoral factor gamma 2"
            ]
        }, 
        "keyword": [
            "Drug Therapy, Combination", 
            "Antiviral Agents", 
            "Zidovudine", 
            "thymic humoral factor gamma 2"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Irvine", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92717"
                    }, 
                    "name": "UCI"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90028"
                    }, 
                    "name": "Southwest Community Based AIDS Treatment Group - COMBAT"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94121"
                    }, 
                    "name": "San Francisco Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sherman Oaks", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91403"
                    }, 
                    "name": "Gottlieb Med Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hollywood", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33021"
                    }, 
                    "name": "Mem Hosp Hollywood"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maitland", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32751"
                    }, 
                    "name": "Goodgame Med Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10014"
                    }, 
                    "name": "Chelsea Village Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Portland Veterans Adm Med Ctr / Rsch & Education Grp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29204"
                    }, 
                    "name": "Dr Alfred F Burnside Jr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Annandale", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22203"
                    }, 
                    "name": "Infectious Disease Physicians Inc"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Study of the Activity of Thymic Humoral Factor (THF Gamma 2) on HIV Load in HIV-Positive Individuals With CD4+ Cell Counts in the Range of 200-500 Cells/mm3", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002435"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pharmacia", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 1998"
    }, 
    "geocoordinates": {
        "Chelsea Village Med Ctr": "40.714 -74.006", 
        "Dr Alfred F Burnside Jr": "34.001 -81.035", 
        "Goodgame Med Group": "28.628 -81.363", 
        "Gottlieb Med Group": "34.149 -118.451", 
        "Infectious Disease Physicians Inc": "38.83 -77.196", 
        "Mem Hosp Hollywood": "26.011 -80.149", 
        "Portland Veterans Adm Med Ctr / Rsch & Education Grp": "45.523 -122.676", 
        "San Francisco Veterans Administration Med Ctr": "37.775 -122.419", 
        "Southwest Community Based AIDS Treatment Group - COMBAT": "34.052 -118.244", 
        "UCI": "33.684 -117.795"
    }
}